DalsnaFinance › IPOs › Aspen Neuroscience, Inc. IPO
Aspen Neuroscience, Inc. completed its initial public offering on Nasdaq on October 29, 2026, pricing at $15.00 a share.
| Ticker | ASPE |
|---|---|
| Exchange | Nasdaq |
| Status | Completed |
| Listing date | October 29, 2026 |
| Offering price | $15.00 |
| Shares offered | 9,375,000 |
| Total raised | $141M |
| Sector | Pharmaceutical Preparations |
Aspen Neuroscience, Inc. listed on Nasdaq on 2026-10-29.
Ingested from SEC EDGAR (424B4, 8-A12B), CIK 2124080.
Aspen Neuroscience, Inc. sold 9,375,000 shares at $15.00 each on Nasdaq. Multiplied out, that is $140.6 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $141 million total recorded for the deal.
Measured by money raised, Aspen Neuroscience, Inc. was the 293rd largest of 458 completed IPOs with a recorded deal size that this site tracks since November 5, 2024. The median deal in the same window raised $200 million.
Among the 10 listings on Nasdaq alone, it is the 8th largest.
October 2026 saw 13 completed IPOs in the site's data; by amount raised, Aspen Neuroscience, Inc. was the 3rd largest of the 3 deals with a recorded size.
Its $15.00 offer price was tied for the 123rd highest (level with 10 other listings) of the 476 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
Source: SEC EDGAR filings for Aspen Neuroscience, Inc.. This page is general information, not investment advice.